# Evaluation of Gixam's Efficacy Predicting Pre-cancerous Colorectal Polyps and Colorectal Cancer

> **NCT06688110** · NA · NOT_YET_RECRUITING · sponsor: **Jubaan Ltd.** · enrollment: 800 (estimated)

## Conditions studied

- Colorectal Cancer
- Colorectal Adenomatous Polyp
- Colorectal Neoplasms

## Interventions

- **DEVICE:** Gixam System

## Key facts

- **NCT ID:** NCT06688110
- **Lead sponsor:** Jubaan Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02
- **Primary completion:** 2026-03
- **Final completion:** 2026-04
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2024-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06688110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06688110, "Evaluation of Gixam's Efficacy Predicting Pre-cancerous Colorectal Polyps and Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06688110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*